Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.1B |
| Enterprise Value | 3.86B |
| P/E Ratio | 30.45 |
| PEG Ratio | 1.05 |
| Price/Sales Ratio | 4.74 |
| Price/Book Ratio | 1.88 |
| Enterprise/Revenue | 4.53 |
| Enterprise/EBITDA | 17.87 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.16 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.06 |
Income Statement
| Revenue | 1.04B |
| Revenue/Share | 2.58 |
| Gross Profit | 605.23M |
| EBITDA | 257.4M |
| Net Income | 131.62M |
| Diluted EPS | 0.33 |
Balance Sheet
| Total Cash | 591.3M |
| Total Cash/Share | 1.47 |
| Total Debt | 122.32M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.47 |
| Book Value Per Share | 6.57 |
Price History
| 52-Week Change | 5.88 |
| 52-Week High | 14.42 |
| 52-Week Low | 8.58 |
| Moving Average 50 Days | 12.04 |
| Moving Average 200 Days | 10.93 |
Statistics
| Average Volume | 27.24M |
| Shares Outstanding | 401.74M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 0.67 |
| Payout Ratio | 0 |
| Last Split Factor | 9:5 |
| Last Split Date | October 12, 2018 |
AD
